Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125036282 | 12503628 | 2 | F | 20160329 | 20160628 | 20160628 | 20160708 | EXP | US-ELI_LILLY_AND_COMPANY-US201606006510 | ELI LILLY AND CO | 55.00 | YR | F | Y | 96.00000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125036282 | 12503628 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK, UNKNOWN | Y | U | 21368 | TABLET | |||||||
125036282 | 12503628 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 5 MG, QD | SBFS | 0 | 5 | MG | QD | ||||||
125036282 | 12503628 | 3 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1504768A | 0 | 10 | MG | QD | ||||||
125036282 | 12503628 | 4 | SS | SILDENAFIL. | SILDENAFIL | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
125036282 | 12503628 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 7 | C | HYDROCODONE | HYDROCODONE | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 8 | C | LASIX | FUROSEMIDE | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 9 | C | LORATADINE. | LORATADINE | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 10 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 11 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 12 | C | RANITIDINE. | RANITIDINE | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 13 | C | TRAMADOL. | TRAMADOL | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 14 | C | TYLENOL | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
125036282 | 12503628 | 15 | C | OXYGEN. | OXYGEN | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125036282 | 12503628 | 1 | Product used for unknown indication |
125036282 | 12503628 | 2 | Pulmonary hypertension |
125036282 | 12503628 | 3 | Scleroderma |
125036282 | 12503628 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125036282 | 12503628 | OT |
125036282 | 12503628 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125036282 | 12503628 | Dyspnoea | |
125036282 | 12503628 | Dyspnoea exertional | |
125036282 | 12503628 | Fatigue | |
125036282 | 12503628 | Fluid overload | |
125036282 | 12503628 | Malaise | |
125036282 | 12503628 | Musculoskeletal chest pain | |
125036282 | 12503628 | Oedema peripheral | |
125036282 | 12503628 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125036282 | 12503628 | 2 | 20160310 | 0 | ||
125036282 | 12503628 | 4 | 20160328 | 0 |